Genflow Biosciences (OTCQB:GENFF) on Wednesday announced that its second European patent application (Application No. 23821586.7, Publication No. EP4630038), titled “SIRT6 Variant for NASH,” has been published in the European Patent Bulletin.
Publication of the patent application in the European Patent Bulletin follows entry into the European phase under the Patent Cooperation Treaty and represents a key milestone in Genflow’s expanding intellectual property portfolio.
Dec. 08, 2025 12:02 PM ETCarvana Co. (CVNA) Stock, GVIP, TCHP, ONLN, CLIXIBUY, UPGD, PDP, PEZ, MILN, NUMG, BOUT, EBIZ,...
“We want to re-industrialize the United States. We need to be back in manufacturing,” Huang said recently on theJoe Rogan...
Recently listed edtech player PhysicsWallah reported 62% year-on-year (YoY) growth in its consolidated net profit at Rs 72.3 crore in...
New York City-based RPD Fund Management sold 237,000 shares of Abercrombie & Fitch in the third quarter. The overall position...
Israel’s fiscal deficit narrowed to 4.5% of GDP at the end of November, or NIS 932.5 billion in absolute...
Microsoft (MSFT) is reportedly discussing plans to co-design custom chips with Broadcom (AVGO) to meet growing demand amid intensifying competition in...
The first and only national digital and print magazine that connects individuals, families, and businesses to Fee-Only financial advisers, accountants, attorneys and college guidance counselors.
